HEMEDEX INC

HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. HEMEDEXs patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood...

Perfusion,neurointensive care,neurosurgery,multilumen bolt kit,parenchymal cbf,neurocritical care,traumatic brain injury,subarachnoid hemorrhage,brain temperature,and thermal conductivity

Hemedex inc operates in the Medical equipment manufacturing industry.

Hemedex inc's revenue is 11m - 100m

Hemedex inc has 11 - 50 employees.